Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA launches new priority review voucher program for select biopharmas
Biotech
US accused of ending grants for biotechs with Chinese investors
HHS is allegedly canceling clinical trial funding for biotechs with ties to certain foreign investors, Fierce Biotech has learned.
Gabrielle Masson
Jun 18, 2025 11:50am
FDA 'on track' to meet all PDUFA dates, Marty Makary says
Jun 18, 2025 4:00am
Sponsored
Unlocking the power of biospecimens
Jun 16, 2025 8:00am
Neuro-focused Draig hatches with red-hot $140M series A
Jun 18, 2025 12:01am
Zealand's dual agonist tied to 11% weight loss in phase 1b
Jun 18, 2025 3:00pm
Fierce Biotech Layoff Tracker 2025: BioNTech, Gilead & more
Jun 18, 2025 12:43pm
More News
Fierce Pharma
Bavarian Nordic's $160M PRV price reflects new realities
Jun 18, 2025 11:47am
Grail plans to submit updated Galleri blood test to FDA in 2026
Jun 18, 2025 11:45am
Caris Life Sciences ups IPO to raise $494M
Jun 18, 2025 11:00am
Fierce Pharma
BioNTech to wind down cell therapy manufacturing in Maryland
Jun 18, 2025 10:23am
